We are live on ! Find out more
DFO

Duquesne Family Office Portfolio holdings

AUM $5.21B
1-Year Est. Return 87.01%
This Fund
S&P 500
This Quarter Est. Return
+2.36%
1 Year Est. Return
+87.01%
3 Year Est. Return
+345.18%
5 Year Est. Return
+545.74%
10 Year Est. Return
+5,317.36%
AUM
$815M
AUM Growth
-$586M
Cap. Flow
-$570M
Cap. Flow %
-69.95%
Top 10 Hldgs %
56.84%
Holding
69
New
24
Increased
2
Reduced
5
Closed
33

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$25.7M
2
GILD icon
Gilead Sciences
GILD
+$21.3M
3
AMGN icon
Amgen
AMGN
+$20.7M
4
MRK icon
Merck
MRK
+$19.4M
5
COST icon
Costco
COST
+$19.1M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$129M
2
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$65.1M
3
META icon
Meta Platforms (Facebook)
META
+$63.8M
4
GDX icon
VanEck Gold Miners ETF
GDX
+$60M
5
WBA
Walgreens Boots Alliance
WBA
+$38.8M

Sector Composition

Rank Sector Weight
1 Healthcare 35.39%
2 Consumer Discretionary 16.43%
3 Communication Services 12.04%
4 Materials 7.93%
5 Miscellaneous 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YPF icon
26
YPF Sociedad Anonima ADS
YPF
$21.9B
$11.1M 1.36%
+298,900
New +$10.5M
XLV icon
27
State Street Health Care Select Sector SPDR ETF
XLV
$43.7B
$11M 1.35%
172,300
– –
BBWI icon
28
Bath & Body Works
BBWI
$3.48B
$10.1M 1.24%
+187,158
New +$9.41M
XLF icon
29
State Street Financial Select Sector SPDR ETF
XLF
$54B
$9.93M 1.22%
488,352
-14,581
-3% -$294K
DIA icon
30
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.4B
$9.91M 1.22%
+58,300
New +$9.87M
JWN
31
DELISTED
Nordstrom
JWN
$9.79M 1.2%
+143,200
New +$9.86M
FL
32
DELISTED
Foot Locker
FL
$9.76M 1.2%
+175,400
New +$9.23M
ARIA
33
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$8.88M 1.09%
+1,645,000
New +$9.61M
LUMO
34
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$3.91M 0.48%
+20,278
New +$4.46M
KITE
35
DELISTED
Kite Pharma, Inc.
KITE
$1.14M 0.14%
+40,000
New +$990K
BABA icon
36
Alibaba
BABA
$268B
$889K 0.11%
+10,000
New +$898K
AAL icon
37
American Airlines Group
AAL
$8.58B
– –
-240,700
Closed -$10.3M
ATI icon
38
ATI
ATI
$26.2B
– –
-510,000
Closed -$23M
AZN icon
39
AstraZeneca
AZN
$253B
– –
-208,900
Closed -$15.5M
BIDU icon
40
Baidu
BIDU
$30.5B
– –
-126,000
Closed -$23.5M
CP icon
41
Canadian Pacific Kansas City
CP
$78B
– –
-460,000
Closed -$16.7M
DHI icon
42
D.R. Horton
DHI
$39.7B
– –
-494,429
Closed -$12.2M
DVN icon
43
Devon Energy
DVN
$54B
– –
-207,500
Closed -$16.5M
EOG icon
44
EOG Resources
EOG
$76.3B
– –
-288,200
Closed -$33.7M
EQT icon
45
EQT Corp
EQT
$32B
– –
-323,128
Closed -$18.8M
EXPD icon
46
Expeditors International
EXPD
$24.8B
– –
-220,000
Closed -$9.71M
FLR icon
47
Fluor
FLR
$7.07B
– –
-192,800
Closed -$14.8M
FXI icon
48
iShares China Large-Cap ETF
FXI
$4.07B
– –
-281,100
Closed -$10.4M
HAL icon
49
Halliburton
HAL
$29.2B
– –
-368,700
Closed -$26.2M
HCA icon
50
HCA Healthcare
HCA
$92.9B
– –
-194,600
Closed -$11M
1
2
3

Similar funds

LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $5.2B AUM 22.05% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
CFC
Cincinnati Financial Corp Fairfield, Ohio $5.23B AUM 22.72% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $5.24B AUM 38.12% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.16B AUM 18.64% 1-Year Est. Return

Duquesne Family Office's Q3 2014 Portfolio in Review

As of Q3 2014, Duquesne Family Office held 69 positions worth $815M, down 42% from $1.4B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Duquesne Family Office withdrew a net $570M in Q3 2014, closing 33 positions and reducing 5 holdings. Its most notable exit was Teva Pharmaceutical Industries Limited, an estimated $65.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Duquesne Family Office opened a new position in Gilead Sciences worth $23.2M.

  • Duquesne Family Office's largest Q3 2014 buy was Gilead Sciences: 217,500 shares worth $23.2M.
  • Duquesne Family Office added most to Celgene Corp in Q3 2014, an estimated $25.7M increase.
  • Duquesne Family Office's biggest Q3 2014 reduction was Alphabet (Google) Class C, cutting an estimated $129M.
  • Duquesne Family Office fully exited Teva Pharmaceutical Industries Limited in Q3 2014, selling an estimated $65.1M.
  • Duquesne Family Office's ten largest holdings make up 57% of its $815M portfolio in Q3 2014.
  • Duquesne Family Office opened 24 new positions and closed 33 in Q3 2014.
  • Duquesne Family Office's portfolio value fell 42% quarter-over-quarter to $815M.

Based on Duquesne Family Office's 13F filing for Q3 2014, filed 14 Nov 2014.